Fingerprint
Dive into the research topics where Martha Lacy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Mayo Clinic Multiple Myeloma SPORE
Bergsagel, L. (PI), Braggio, E. D. (CoPI), Vachon, C. M. (CoPI), Chesi, M. (CoPI), Dueck, A. (CoPI), Fonseca, R. (CoPI), Geyer, S. (CoPI), Jelinek, D. F. (CoPI), Lacy, M. (CoPI), Stewart, A. K. (CoPI) & Lin, Y. Y. (CoPI)
9/1/15 → 8/31/26
Project: Research project
-
Project 1: Optimizing a VSV-based virotherapy-based regimen for advanced MM
Lacy, M. (PI) & Lacy, M. M. Q. (PI)
9/15/21 → 8/31/23
Project: Research project
-
Academic Promotions in Medicine: Characterizing Differences in Curriculum Vitae Across Race and Sex
Warsame, R., Kim, Y. H., Ouk, M. Y., Cole, K. C., Lacy, M. Q., Hayes, S. N., Shalle, Z., Balls-Berry, J., Jordan, B. L., Wolanskyj-Spinner, A. P., Spinner, R. J. & Enders, F. T., Feb 2025, In: Mayo Clinic proceedings. 100, 2, p. 249-264 16 p.Research output: Contribution to journal › Article › peer-review
-
Cumulative deficits frailty index and relationship status predict survival in multiple myeloma
Abdallah, N., Dizona, P., Kumar, A., LaPlant, B., Menser, T., Schaeferle, G., Aug, S., Weivoda, M., Dispenzieri, A., Buadi, F. K., Warsame, R., Cook, J., Lacy, M. Q., Hayman, S., Gertz, M. A., Rajkumar, S. V. & Kumar, S. K., Mar 11 2025, In: Blood Advances. 9, 5, p. 1137-1146 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Eliminating the need for sequential confirmation of response in multiple myeloma
Claveau, J. S., Kapoor, P., Binder, M., Buadi, F., Dingli, D., Dispenzieri, A., Fonder, A., Gertz, M., Gonsalves, W., Hayman, S., Hobbs, M., Hwa Christenson, Y. L., Kourelis, T., Lacy, M., Leung, N., Lin, Y., Warsame, R., Kyle, R., Rajkumar, S. V. & Kumar, S. K., Aug 14 2025, In: Blood. 146, 7, p. 802-805 4 p.Research output: Contribution to journal › Article › peer-review
-
From CyBorD to dara-CyBorD, ASCT utilization trends in AL amyloidosis: a 15-year analysis
Muchtar, E., Dispenzieri, A., Buadi, F. K., Kapoor, P., Dingli, D., Kourelis, T. V., Gonsalves, W., Leung, N., Hayman, S. R., Lacy, M. Q., Siddiqui, M., Cook, J., Abdallah, N., Binder, M., Zanwar, S., Hogan, W., Warsame, R., Rajkumar, S. V., Kumar, S. K. & Gertz, M. A., Aug 26 2025, In: Blood Advances. 9, 16, p. 4311-4316 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Improved survival with daratumumab-CyBorD compared with CyBorD as frontline therapy for AL amyloidosis
Yohannan, B., Rees, M., Gertz, M. A., Dispenzieri, A., Kapoor, P., Buadi, F. K., Dingli, D., Leung, N., Lacy, M. Q., Hayman, S. R., Gonsalves, W., Kourelis, T., Cook, J., Binder, M., Siddiqui, M., Lin, Y., Hwa, L., Rogers, M. G., Hobbs, M. & Fonder, A. & 4 others, , May 2025, In: Blood Neoplasia. 2, 2, 100092.Research output: Contribution to journal › Article › peer-review
Open Access